The recent advances in molecular profiling, directed therapies and early detection of cancer have brought the traditional techniques of diagnosis to the edge of their capabilities. In this chapter, we will analyze the challenges of new discoveries in cellular signaling network have in the early ...
In addition, it has been proved that IDH mutation is a good prognostic marker for glioma by RNA-seq [83]. Targeted therapy is also considered to enhance or replace cytotoxic chemotherapy regimen in cancer including AML [84,85,86]. ScRNA-seq also has some new discoveries in diagnosis. For ...
Recent discoveries show that other options are also possible. One of these options for cancer treatment is invented by Dr. Yamamoto. In the early 1990s, Dr. Yamamoto first described how the human immune system is disengaged by enzymes secreted from cancer cells, even filing a patent on the ...
Massively parallel DNA and RNA sequencing approaches have generated data on thousands of breast cancer genomes. In this review, we consider progress largely from the perspective of new concepts and hypotheses raised so far. These include challenges to th
Human chorionic gonadotropin (hCG) is a glycoprotein hormone comprising 2 subunits, alpha and beta joined non covalently. While similar in structure to luteinizing hormone (LH), hCG exists in multiple hormonal and non-endocrine agents, rather than as a s
Watch the latest science news, discoveries and big ideas fromNew Scientist's video team Video Perfect chocolate-caramel Swiss roll recipe by Bake Off's Josh Smalley Video Free Video The sci-fi films and TV that explore AI in eerily prescient ways ...
“Investing in cancer research is vital, as seminal discoveries in the laboratory translate to cancer treatments of the future. As New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute is committed to mentoring the next generation of ...
“It’s an exciting time to join Allegheny Health Network’s Cancer Institute as we embrace new discoveries and apply innovative therapies to treat the most challenging cancer cases,” said Dr. Lopez-Chavez. “From the latest technologies in targeted therapies, immunotherapies, and cellu...
It provides the fastest possible publication of new discoveries for scientists developing anticancer agents. The journal also publishes proceedings of special workshops and symposia on anticancer drug development. It is open to publishing clinical trials with negative results if they contribute to the ...
The field of cancer glycoproteomic biomarker studies is evolving rapidly with encouraging discoveries in cancer screening/early diagnosis, therapeutic prediction, and monitoring, among others. While these glycoproteomic signatures represent a promising possibility to serve as biomarkers, the field still faces...